US3812854A - Ultrasonic nebulizer - Google Patents
Ultrasonic nebulizer Download PDFInfo
- Publication number
- US3812854A US3812854A US00299194A US29919472A US3812854A US 3812854 A US3812854 A US 3812854A US 00299194 A US00299194 A US 00299194A US 29919472 A US29919472 A US 29919472A US 3812854 A US3812854 A US 3812854A
- Authority
- US
- United States
- Prior art keywords
- liquid
- horn
- porous
- liquid medicament
- porous body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0623—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn
- B05B17/063—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn having an internal channel for supplying the liquid or other fluent material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0623—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers coupled with a vibrating horn
Definitions
- ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
- This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.
- a common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy.
- Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West).
- micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.
- micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.
- respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc.
- drugs used to treat these diseases for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.
- Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.
- Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).
- the respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.
- a further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.
- a further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.
- Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.
- Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.
- a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.
- FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention
- FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention.
- FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.
- an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure.
- Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14.
- Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14.
- the frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof.
- Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency.
- Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19.
- Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11.
- FIG. 1 the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.
- liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11.
- the pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11.
- the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.
- liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure.
- Aerosol particle size is a function Particle diameter 2 X pore diameter
- the aerosol particles which result are uniformly from about 18 to 22 microns in diameter.
- an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.
- a body having pores of a variety of sizes When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.
- pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.
- the size of the outer pores of the porous body should be fixed.
- the material of construction of the porous body is not critical so long as it provides a fixed pore size.
- Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.
- the porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.
- the porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution.
- an internal macroporous layer which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution.
- Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.
- the porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs.
- the size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.
- the porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved.
- the antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14.
- Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers.
- a high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz.
- the power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.
- Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12.
- Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized.
- Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved.
- the pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.
- a great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1.
- Water and aqueous solutions such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises.
- Viscous liquids such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body.
- Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations.
- Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.
- Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.
- bronchodilator decongestants for example, epinephrine, isoproterenol, isoetharime and phenylephrine
- moistening thinning and detergent solutions such as superinone
- mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme
- water or saline humidity for example, water or saline humidity.
- FIG. 2 a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy.
- the principle components of this inhaler inhaler 2 are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18.
- Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle.
- This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22.
- Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11.
- Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired.
- Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration.
- This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired.
- the volume may be simply derived by detecting and integrating the inspiration velocity.
- the nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.
- the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.
- Atomizer 3 suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown.
- Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized.
- Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29.
- Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16.
- Liquid to be nebulized for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12.
- Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11.
- the atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32.
- carrier gas which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31.
- a mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.
- EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed.
- porous body 11 As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns.
- This body is glued on horn 12, care being taken to avoid blocking the pores of body 11.
- Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches.
- Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches.
- a 0.50 inch piezoelectric ceramic is used as crystal [4.
- a Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15.
- Channel 19 is connected to a Harvard infusion pump.
- a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11.
- Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.
- Example 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.
- Example 3 The experiment of Example 1 is repeated with one modification.
- the antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip.
- Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi.
- An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.
- EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.
- EXAMPLE 5 a An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.
- part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.
- Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.
- EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph.
- An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter.
- the mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31.
- An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.
- An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:
- porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
- nebulizer adapted to atomize the liquid medicament for inhalation by a patient and including:
- a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
- An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
- An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
- An ultrasonic nebulizer including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.
Abstract
A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
Description
ilnited States Patent Michaels et a1.
[ May 28, 1974 Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Thomas E. Ciotti; Edward L. Mandell; Paul L. Sabatine [57] ABSTRACT A device for the ultrasonic nebulization of liquids. Nebulization takes place in a porous solid body the porosity of which determines the size of the liquid particles generated. The device is especially suitable for nebulizing liquid medicaments for inhalation therapy.
8 Claims, 3 Drawing Figures 1 1 ULTRASONIC NEBULIZER [76] lnventors: Alan S. Michaels, 97 Mt. Vernon,
Atherton; Richard G. Buckles, 491
Middle Ct., Menlo Park, both of Calif. 94025; Michael P. Keller, 2272 Latham St., Mountain View, Calif. 94040 [22] Filed: Oct. 20, 1972 [21] App]. No.: 299,194
[52] US. Cl 128/194, 128/D1G. 2, 239/102 [51] Int. Cl A6lm 15/00 [58] Field of Search 128/194, DIG. 2, 172, 173, 128/193, 145.8, 145.6; 259/D1G. 44; 239/102, 4, 338
[56] References Cited UNITED STATES PATENTS 2,658,169 11/1953 Barret 128/172 x 2 1&4
18 HIGH FREQUENCY G EN ERATOR RNTENIENNN RM I $812,854
/l4 [2 HIGH x FREQUENCY GENERATOR x LIQUID I N; IG.I F SUPPLY I? I LIQUID MOMMA l GENERATOR 16 I8 Y SUPPLY 1 ULTRASONM NEBULIZER BACKGROUND OF THE INVENTION 1. Field Of The Invention This invention relates to ultrasonic nebulizers. More particularly, it relates to a device for ultrasonically producing liquid aerosols having controlled particle size. In a preferred embodiment, the invention relates to an improved ultrasonic nebulizer for inhalation therapy.
2. The Prior Art The art is replete with processes which employ aerosols of liquids. Paints, biocides, personal and home care products, gas chromatography and spectroscopy samples, and inhalable drugs are representative of the many materials which are advantageously employed as aerosols. Most commonly, aerosols are generated by drawing the liquid into a high velocity stream of propellant gas. With the growing awareness of the health hazards posed by many of the known propellants, especially the Freon-type gases, other methods of generating aerosols are receiving increased attention.
It is known that aerosols can be generated ultrasonically. A common form of ultrasonic nebulizer achieves atomization by the disintegration of the geyser which is produced in a body of liquid by contacting the liquid with a focused beam of ultrasonic compressed wave energy. Devices of this type have been used, for example, in inhalation therapy (see U.S. Pat. No. 3,561,444 issued Feb. 9, l97l to Boucher or No. 3,387,607 issued June 1 1, 1968 to Gauthier et al.) and in sample atomization (see U.S. Pat. No. 3,325,976 issued June 20, 1967 to West). Another known type of ultrasonic nebulizer achieves atomization by dripping the liquid to be dispersed onto a continuously ultrasonically vibrating solid plate which breaks the liquid into a variety of particles. Such a device is shown in U.S. Pat. No. 3,291,122 issued Dec. 13, 1966 to Engstrom et al.
known that the point at which an aerosol particle deposits in the respiratory system is a function of particle size; micron particles are laid down in the mouth and larynx, 6 to 9 micron particles are preferentially.
deposited in the bronchi, 3 to 6 micron particles are preferentially deposited in the bronchioli, 1 to 3 micron particles are deposited in the alveoli, while particles much smaller than about 1-micron are not retained in the respiratory system by Brownian collision with all walls; most of these particles are exhaled.
Many respiratory diseases affect only one-of the areas of the respiratory system: for example, pneumonia and emphysema affect the alveoli, bronchitis affects the bronchioli, asthma affects the bronchi or bronchioli, etc. Since the drugs used to treat these diseases, for example, epinephrine, norepinephrine, prostaglandins, steroids, antibiotics, detergents and the like are often highly potent and/or systemically toxic, it would be of utmost advantage to minimize drug dosage by delivering the drug precisely to the affected area. More precise particle size control than possible heretofore would help minimize extraneous drug applications.
Another way to reduce drug dosage during inhalation therapy would be to deliver the drug as a precisely timed pulse. It has been found that the flow of gas in and out of the respiratory system has essentially plug flow characteristics with the first gas inspired eventually filling the most distant alveoli, the last gas inspired filling only the larynx, etc. Precise delivery of an accurately determined pulse of atomized drug at an accurately determined point during inspiration, thus would result in further control of the location of drug deposit.
Prior ultrasonic nebulizers are not suitable for accurate Both of these conventional types of nebulizing devices can effectively continuously produce large volumes of crude aerosol but both have three serious disadvantages when preceise nebulization is desired. First, they do not permit accurate control of the amount of liquid atomized; second, they also require relatively long times (often I to 10 seconds) after starting to generate a stable consistent aerosol, and finally, they fail to directly generate an aerosol having uniformly sized particles (so-called monodispersed aerosols).
This last failing is especially serious since it is often necessary or desirable to have a monodispersed aerosol. On a theoretical basis, it has been shown that continuous ultrasonic nebulizers should produce uniform particles related in diameter to the reciprocal of the ultrasonic frequency employed. In practice, however, prior ultrasonic atomizers have produced a variety of extraneous large particles which must be screened, settled or otherwise removed, albeit incompletely, as may be noted in U.S. Pat. No. 3,291,122 and Boucher et al. 26 Annals ofAllergy 591 at FIG. 4 (1968). This inability to control particle size has limited the usefulness of conventional ultrasonic nebulizers especially in inhalation treatment of the respiratory system where precise control of particle size is most advantageous and true monodispersed aerosols have been long desired.
The respiratory system comprises a series of decreasing diameter branched tubes, including the mouth, larynx, trachea, bronchi, bronchioli and alveoli. It is pulsed delivery. These devices often require at least several seconds of tuning to achieve a usable aerosol. When used in pulsed applications, conventional ultrasonic nebulizers rely upon interrupting the transmission of the aerosol by bulky ducts and poorly controllable valves rather than by controlling the aerosols generation.
OBJECTS OF THE INVENTION Accordingly, it is an object of the present invention to provide a new and improved nebulizer of the ultrasonic type.
A further object of this invention is to provide an ultrasonic nebulizer which will permit precise control of the amount of liquid nebulized.
A further object of this invention is to provide an ultrasonic nebulizer which will permit control of the size of liquid particles formed.
Another object of this invention is to provide a device for the production of aerosols which may be used with improved efficiency for inhalation therapy or other therapeutic purposes.
Yet another object of this invention is to provide an ultrasonic nebulizer for inhalation therapy which can be controlled to deliver a medicament-containing aerosol in the form of a pulse of particular particle size and amount of medicament; positioned at a particular point in the inspiration cycle.
STATEMENT OF THE INVENTION It has now been found that the foregoing objects, as well as other objects, advantages, and features which will become apparent from the detailed description to follow, are attained by a nebulizer which includes a porous body having a defined intercommunicating pore structure, an oscillator capable of vibrating the porous body at an ultrasonic frequency and a system for supplying liquid to be nebulized to the pores of the porous body.
BRIEF DESCRIPTION OF THE DRAWINGS In the drawings,,..wherein like reference numerals designate like parts:
FIG. 1 is an essentially diagrammatic cross-sectional view of an embodiment of the ultrasonic nebulizer of the invention;
FIG. 2 is an essentially diagrammatic cross-sectional view of another configuration of a nebulizer of the invention, and
FIG. 3 is a cross-sectional view of yet another configuration of the nebulizer of the invention.
DETAILED DESCRIPTION OF THE INVENTION As illustrated in FIG. 1, an ultrasonic nebulizer l embodying the present invention has a porous solid body 11 having a defined fixed intercommunicating pore structure. Solid body 11 is affixed to ultrasonic horn or antennuator 12 which is in turn attached to a suitable piezoelectric crystal or other electro-mechanical transducer 14. Crystal 14 is connected via cable 16 to high frequency signal generator which produces an ultrasonic signal of adequate power to oscillate crystal 14. The frequency generated by generator 15 is very suitably the resonant frequency of crystal 14 or a harmonic thereof. Cable 16, generator 15, crystal l4 and horn 12 in combination cause porous body 11 to vibrate at an ultrasonic frequency. Liquid to be nebulized is forced under pressure from liquid supply 17 through conduit 18 through concentric channel (or bore) 19 in horn 12 to the interconnected pores of porous body 11 which communicate with channel 19. Conduit 18 is attached to horn 12 in a manner which does not interfere with the ultrasonic oscillation of horn l2 and porous body 11. As will be appreciated by those skilled in the art, the embodiment of the invention illustrated in FIG. 1 is much simplified to clearly set out the invention. Details, such as for example a housing for the nebulizer or the method of flexibly attaching crystal 14 to the hous ing or the exact method of fastening conduit 18 to channel 19, may be supplied by one skilled in the art without departing from the spirit of this invention. Likewise, minor modifications, such as the addition of a capability for cooling crystal 14, may be employed.
In operation, liquid to be nebulized is passed through conduit 18 and channel 19 to porous body 11. The pores of body 11 are intercommunicating, so that liquid can be conducted through solid body 11. Thus the liquid from channel 19 moves to the outer surface of porous body 11 and there is nebulized by the ultrasonic vibration into an aerosol having a particle size distribution which is related to the diameters of the pores of body 11.
In accordance with the present invention, liquids are nebulized to aerosols using an ultrasonically vibrating porous body having a fixed pore structure. Unlike prior ultrasonic nebulizers wherein the size of the particles in the aerosol was determined by the frequency of the ultrasonic vibration, the particle sizes achieved with the instant nebulizers are related to the internal geometry of this porous body. Aerosol particle size is a function Particle diameter 2 X pore diameter For example, when a porous body having uniform 10 micron pores is used in the present invention, the aerosol particles which result are uniformly from about 18 to 22 microns in diameter. When a porous body having uniform 4 mircon diameter external surface pores is substituted an aerosol having particles from about 7 to 9 micron in diameter is formed. This particle size to pore diameter relationship appears to hold over the range of body external pore diameters of from about 0.5 micron to about 50 microns.
When a body having pores of a variety of sizes is employed, a multi-sized aerosol is obtained. In the preferred embodiments of this invention, wherein aerosols for inhalation therapy are produced, it is most often preferred to have uniform particle sizes. Bodies having uniform pore diameters in the range of from 0.5 to 5 microns produce aerosols ideal for many inhalation applications. Most specifically, bodies having all or a major proportion of their pores in the range of from 0.5 to 1.5 microns produce aerosols excellentfor inhalation treatment of the alveoli, bodies having their pores in the range of from 1.5 to 3 microns produce aerosols well suited for treating the bronchioli, while 3 to 5 micron pore bodies produce aerosols most useful for treating the bronchi. As used herein, a body is defined to have a uniform pore diameter within a range when at least about percent of all its pores fall within the given range. Preferably at least about percent of all the pores fit within the specified range.
The pores of the porous body must be joined into an intercommunicating network since when used in accord with this invention, liquid will be passed from one side of the porous body through to the other side.
To achieve reproducible results, the size of the outer pores of the porous body should be fixed. The material of construction of the porous body is not critical so long as it provides a fixed pore size. Porous ceramic oxides may be used as well as porous glasses and metal frits, compressed porous plastics, and certain filters (e.g., nucleopore). These materials are readily available, being used conventionally as filters and catalyst supports.
The porous body should be relatively thin, generally not more than about 1 or 2 cms thick, preferably from 0.01 to 1 cm thick. Undesirably large amounts of energy are required to force the liquid to be nebulized through thicker bodies.
The porous body may be comprised of several layers, for example an internal macroporous layer, which permits the facile passage of liquid, in combination with an outer layer or skin having the required pore size distribution. Such a material can be made by carefully annealing or firing the surface of a macroporous support or by bonding a thin sheet of microporous ceramic, for example 0.005 cm thick, to a sheet of macroporous ceramic, for example 1 cm thick.
The porous body must be vibrated ultrasonically to produce the desired aerosol. This may be carried out by connecting the body to an ultrasonic vibrator such as, for example, by affixing the body to a piezoelectric ceramic crystal. This connection is preferably made through an antennuator horn, which when correctly matched to the piezoelectric crystal frequency, effeciently transmits the ultrasonic oscillation of the piezoelectric crystal to the porous body and if sized correctly permits the ultrasonic energy to be multiplied and focused in the porous body where nebulization occurs. The size and shape of the antennuator horn 12 is not critical. Ideally, it is sized taking into consideration its material and the velocity of ultrasonic waves therethrough to achieve a harmonic relationship at the frequency employed.
The porous body is attached or affixed to the antennuator horn by a method enabling a tight fit and firm attachment to be achieved. The exact method of affixing the porous body to the antennuator horn, while not critical, must be chosen with care. A tight fit must be achieved. Glueing or soldering can be used so long as the pores of the porous body are not blocked or appreciably obstructed. Clamping or threading the porous body to the antennuator horn are acceptable means of attachment.
The antennuator horn is attached to a piezoelectric ceramic crystal or transducer 14. Piezoelectric crystals and their use as transducers are well known. They may be made of materials such as lead zirconate or titanate, and calcium zironate or titanate, with or without traces of salts, for example yttrium, lanthanum, strontium or cobalt. To permit good electrical contact, they generally are coated on two opposite faces with electrically conducting metallic layers. A high frequency signal generator drives the piezoelectric crystal. This generator is capable of producing a signal having a frequency of from l5.00 kilohertz (Khz) to about 100.00 Khz. The power output required depends upon the amount of liquid being nebulized per unit time and the area and porosity of the porous body. As a general rule, at least 20,000 dyne-cm are needed to nebulize 1 cc of liquid into less than 20 micron particles. Best results are obtained when the power output is from about 1 X to about 1 X 10 dyne-cm.
Liquid to be nebulized is supplied to the porous body through channel 19 in antennuator horn 12. Channel 19 is illustrated as coaxial with horn 12. This is not critical. It is essential that channel 19 contact body 11 in a manner that the pores of body lll can communicate with channel 19 and that liquid passing through channel 19 can pass through the pores to the surface of body 11 and there be nebulized. Liquid is fed to channel 19 under pressure via conduit 17 from liquid supply 16. It is required that the liquid be fed under pressure if a substantial feed rate is to be achieved. The pressure employed will depend on the pore size of body 11, the viscosity of the liquid being fed, etc. Generally, pressure of from I to 20 psi are suitable and may be achieved by for example, moving the liquid with pumps, compressed gas cylinders and the like.
A great variety of liquids may be nebulized by an apparatus as illustrated in FIG. 1. Water and aqueous solutions, such as of drugs, herbicides, dilute paints and dyes and the like are suitable, as are non-aqueous liquids and solutions having viscosities not appreciably greater than about 500 centipoises. Viscous liquids, such as heavy oils, generally are not suitable for nebulization with the present apparatus as they tend to clog the porous body. Light organic materials such as lower hydrocarbons, oxyhydrocarbons and liquid halohydrocarbons may be easily nebulized for a variety of uses such as for flame spectrographic analysis and similar scientific investigations. Liquid medicaments, both neat and in aqueous and non-aqueous solutions which meet the above viscosity criteria are very suitably nebulized by the device of this invention.
Medicaments which may be administered to the respiratory tract by the present invention include conventional inhalation therapy substances such as bronchodilator decongestants, for example, epinephrine, isoproterenol, isoetharime and phenylephrine; moistening thinning and detergent solutions such as superinone; mucolytic agents such as acetylcystune and enzymes, for example pancreatic enzyme; and water or saline humidity.
Turning now to FIG. 2, a diagrammatic illustration is given of an embodiment of the nebulizer of this invention adapted for use as an inhaler for inhalation therapy. The principle components of this inhaler inhaler 2) are the same as those of the nebulizer of FIG. 1, including porous body 11, antennuator horn l2, piezoelectric crystal 14, signal generator 15, cable 16 and liquid supply system 17, here shown as a pressure canister; connected to channel 19 via conduit 18. Inhaler 2 also has, in combination with the foregoing components, a mouthpiece 20 adapted at one end to fit the patients mouth and to admit air as well as medicament through its other end as illustrated, as well as means for automatically controlling the nebulizer during the respiration cycle. This automatic control includes an inspiration responsive detector 21, positioned in the airstream of mouthpiece 20, which reacts to changes in the velocity or pressure of the airstream within mouthpiece 20 thus signalling the commencement of inspiration to control 24 via means 22. Control 24 then opens valve 25 via line 26 and admits the desired amount of medicament from supply pressure canister 17, to line 18, channel 19 and porous body 11. Control 24 also turns on, via line 27, high frequency generator 15 which activates piezoelectric crystal 14 which ultrasonically vibrates horn 12 and attached porous body 11 to nebulize precisely the amount of medicament desired. Inhalation detector 21 and controller 24 may be set to deliver medicament throughout the inspiration cycle or in an especially advantageous mode of operation may be set to order a short burst (say from 0.1 to 1 second) of medication ata preset point during inspiration. This point may be based on the length of time from the start of inspiration or more preferably may be based on the volume of gas inspired. The volume may be simply derived by detecting and integrating the inspiration velocity. The nebulizer of this invention can produce a stable cosistant aerosol of uniform particle size essentially instantaneously, for example, within about 2 milliseconds. Thus it is possible to precisely-insert a burst of aerosolized medicament at any desired point in the inspiration cycle and therefore achieve much improved control of inhalation medicament delivery.
Although these constructional details are not illustrated, the inhaler of FIG. 2 can be constructed suitable for stationary or portable use. Because of the excellent direct control of particle size and amount of medicament nebulized, possible with the present invention, bulky filters, classifiers and the like are not required. Also, the electrical power demands of the inhaler of FIG. 2 are modest. Thus it can be constructed, if desired, to be battery operated in a highly portable form.
Turning now to FIG. 3, an embodiment of the invention, atomizer 3, suitable for generating bulk inhalation aerosols or for nebulizing liquid chemical samples for spectrographic or chromatographic analysis is shown. Atomizer 3 is similar to the embodiments of FIGS. 1 and 2 and includes porous body 11, which is here illustrated, not to scale, as a two layer body having a thin (0.05 cm) outer layer having the pore geometry which will give the particle size distribution desired the thicker (0.5 cm) inner layer having a macroporous structure adapted for the facile passage of liquid to be nebulized. Porous body 11 is attached to antennuator horn 12 by means of threaded compression collar 29. Horn 12 is attached to piezoelectric crystal 14 which is driven by ultrasonic oscillations generated by high frequency generator 15 and transmitted via cable 16. Liquid to be nebulized, for example water, is supplied under pressure by liquid supply 17 and line 18 to channel 19 on horn 12. Channel 19 is branched at its upper end where it contacts body 11. This facilitates the more ready passage and even distribution of liquid into body 11. The atomizer is mounted in housing 30, which is essentially sealed except for carrier gas inlet 31 and outlet 32. In operation, carrier gas, which for inhalation uses is usually air or oxygen containing a blend of gasses and for sample atomization is usually a noninterfering gas such as helium or nitrogen, is passed into housing 30 in inlet 31. A mixture of nebulized liquid and carrier gas is then withdrawn via outlet 32 and used as intended by means not shown.
- The following examples are merely illustrative of the present invention and are not to be considered as limiting the scope of the invention in any way.
EXAMPLE I An ultrasonic nebulizer, substantially as shown in FIG. I, is constructed. As porous body 11 is employed a 0.1 cm thick, 0.5 cm diameter disc of porous ceramic (aluminum oxide), having a relatively uniform porosity (some pores are as large as l or 12 microns, some are as small as about 4 microns) and a mean pore diameter of 6 microns. This body is glued on horn 12, care being taken to avoid blocking the pores of body 11. Antennuato'r horn 12 is constructed from brass and has the following dimensions: length, 3.12 inches, large diameter 0.45 inches, small diameter 0.20 inches. Channel 19 is coaxially bored in horn l2 and it has a diameter of 0.025 inches. A 0.50 inch piezoelectric ceramic is used as crystal [4. A Hewlett-Packard signal generator and McIntosh 2 l 00 Amplifier having a power output of 205 watts is employed as generator 15. Channel 19 is connected to a Harvard infusion pump. In operation, a 30.00 kilohertz oscillation of l8.2 watts power is applied to antennuator horn l2 and porous body 11. Water is pumped to porous body 11 at 20 psi pressure. The water nebulizes and is emitted from body 1 1 as an aerosol having particle diameters of from about 8 to about 20 microns corresponding to two times the diameter of the pores of body 11.
EXAMPLE 2 The experiment of Example I is repeated with one modification. As porous body 11 is employed a similarly sized disc of porous ceramic having a mean pore diameter of microns. The aerosol produced in this experiment has an average particle size of about microns.
EXAMPLE 3 The experiment of Example 1 is repeated with one modification. The antennuator horn having an internal bore and a porous ceramic tip is replaced with a solid horn having no ceramic tip. Liquid is fed to the end of the horn via an external 0.040 inch diameter'tube and a Harvard Positive Displacement pump, operated at 10 psi. An ultrasonic frequency varying from 25 KHz to KHz is applied, with energies of from X 10 400 X 10" dyne-cm. Throughout these ranges of frequencies and energies only randomly sized l0 70 micron particles of liquid are formed.
EXAMPLE 4 A series of experiments in accord with the experiment of Example 1 are conducted. In three experiments the liquid flow rate is varied from 0.0817 [Ll/SEC to 0.4l7 (Ll/Sec. The power requirement changes from 29 watts to 18 watts as the liquid feed is decreased. (all at 30 KHz). The particle size of the resulting aerosol remains constant averaging 15 microns.
In three additional experiments the glued porous body is replaced by a body of the same material attached by a threaded brass collar. Because of the resulting change in horn mass a new frequency (28 KHz) is found to be optimum. The aerosol particle sizes are the same as in the first three experiments. The power requirements at similar flow rates are reduced to form 18 to ll watts.
EXAMPLE 5 a. An inhaler substantially in accord with FIG. 2 is constructed. As liquid is employed a solution of medicament comprising epinephrine in distilled water. Controller 24 is set to order nebulization of medicament throughout the inspiration cycle. As porous body 11 is employed a glass frit having a uniform pore diameter of 5 to 6 microns. A patient inhales through mouthpiece 20. This flow of air is noted by detector 2]. Controller 24, responding to the signal of detector 21, then opens valve 25 and energizes high frequency generator 15 which in turn actuates crystal 14 which vibrates horn 12 and porous body 11. The medicament is nebulized into an aerosol having 10 to l2 micron particles which is inspired by the subject. These particles preferentially deposit on the throat and larynx of a patient employing the inhaler.
b. The experiment of part (a) is repeated using a 3 to 5 micron pore size glass frit. An aerosol having 6 to 10 micron particles is formed. This aerosol deposits preferentially in an inhaling patients bronchi.
c. Similarly, when a l to 2 micron frit is used, a 2 to 4 micron aerosol is formed, which deposits preferentially in a patients alveoli.
d. The experiment of part (c) is repeated with one change. Controller 24 is set to deliver only a short pulse of aerosol positioned at the initial portion of the inspiration cycle. In this case, the particles of medicament tiavell to and are primarily deposited in the most distant a V60 1.
EXAMPLE 6 A sample of lower ketones is to be analyzed by flame photometric detector gas chromatograph. An aerosolizer in accord with FIG. 3 is constructed using a bilayer ceramic porous body, the outer layer having an average 9 pore diameter of 2 microns, the inner having a 30 mircon average pore diameter. The mixed ketones are fed to the porous body, a suitable ultrasonic frequency is applied and a suitable carrier gas is fed via inlet 31. An aerosol of ketone is produced by the nebulizer and is carried therefrom by a carrier gas through the chromatograph to a flame photometeric detector where it is analyzed.
We claim as our invention:
1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination:
A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns;
B. means for supplying said liquid medicament to said porous body; and
C. means for vibrating said porous body comprising:
2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.
3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.
4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including:
D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication with the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and afiixed porous solid body at a frequency of from about 15 Khz to about Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said air stream.
Claims (8)
1. An ultrasonic nebulizer for atomizing a liquid medicament comprising in combination: A. a porous solid body having a defined intercommunicating pore structure adapted to receive said liquid medicament, pass said liquid medicament through its pores and discharge said liquid medicament through one of its ends, the diameters of at least 75 percent of the pore openings in said one end being in the range of from 0.5 to 5 microns; B. means for supplying said liquid medicament to said porous body; and C. means for vibrating said porous body comprising: a. an electronic signal generator; b. a transducer operatively connected to said generator; and c. an antennuator horn interconnecting the transducer and porous solid body, whereby the porous body is vibrated causing the liquid medicament to discharge from said one end as an aerosol, the sizes of the particles thereof being directly proportional to the diameters of said pore openings.
2. The nebulizer according to claim 1 wherein at least 85 percent of said diameters are in said range.
3. The nebulizer according to claim 1 wherein the sizes of said particles are essentially twice the diameters of said pore openings.
4. The nebulizer according to claim 1 wherein the porous body comprises an internal macroporous layer which permits facile passage of said liquid medicament and an outer porous layer whose exterior surface defines said one end.
5. The nebulizer according to claim 1, said nebulizer being adapted to atomize the liquid medicament for inhalation by a patient and including: D. a mouthpiece for transferring the atomized liquid medicament from said one end of the porous body to the mouth of the patient, one end of which communicates with said one end of the porous body and the other end of which is adapted to be received within the mouth of the patient.
6. An ultrasonic nebulizer for atomizing a liquid according to claim 1 wherein the means for supplying liquid to the pores of the porous solid body comprises means for supplying liquid under pressure to a bore in the antennuator horn, which bore communicates with the pores of the porous solid body.
7. An ultrasonic nebulizer for atomizing a liquid medicament for inhalation by a patient comprising in combination, a cylindrical antennuator horn having a large diameter end and distal therefrom a small diameter end and a passageway extending from the small diameter end coaxially through the horn to an external opening; a porous solid body having external pores of diameter of from 0.5 microns to 5 microns affixed to the small diameter end of the antennuator horn, and having a defined intercommunicating pore structure in communication wiTh the passageway; liquid supply means for supplying the liquid medicament to the external opening of the passageway; vibrating means for vibrating the cylindrical antennuator horn and affixed porous solid body at a frequency of from about 15 Khz to about 100 Khz; and a mouthpiece one end of which communicates with said external pores and the other end of which is adapted to be received within the mouth of the patient.
8. An ultrasonic nebulizer according to claim 7 including an inspiration responsive detector positioned within the airstream in said mouthpiece and operatively interconnected with said liquid supply means and said vibrating means, said detector being adapted to activate the liquid supply means and vibrating means in response to physical changes it detects within said airstream.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00299194A US3812854A (en) | 1972-10-20 | 1972-10-20 | Ultrasonic nebulizer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00299194A US3812854A (en) | 1972-10-20 | 1972-10-20 | Ultrasonic nebulizer |
Publications (1)
Publication Number | Publication Date |
---|---|
US3812854A true US3812854A (en) | 1974-05-28 |
Family
ID=23153709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00299194A Expired - Lifetime US3812854A (en) | 1972-10-20 | 1972-10-20 | Ultrasonic nebulizer |
Country Status (1)
Country | Link |
---|---|
US (1) | US3812854A (en) |
Cited By (207)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3912168A (en) * | 1975-01-30 | 1975-10-14 | Teledyne Ind Inc Teledyne Aqua | Irrigation lavage |
US4106503A (en) * | 1977-03-11 | 1978-08-15 | Richard R. Rosenthal | Metering system for stimulating bronchial spasm |
US4109863A (en) * | 1977-08-17 | 1978-08-29 | The United States Of America As Represented By The United States Department Of Energy | Apparatus for ultrasonic nebulization |
US4119096A (en) * | 1975-08-25 | 1978-10-10 | Siemens Aktiengesellschaft | Medical inhalation device for the treatment of diseases of the respiratory tract |
US4261512A (en) * | 1979-02-24 | 1981-04-14 | Boehringer Ingelheim Gmbh | Inhalation aerosol spray device |
US4292973A (en) * | 1977-09-25 | 1981-10-06 | Kabushiki Kaisha Kurio-Medikaru | Apparatus for refrigeration treatment |
US4541966A (en) * | 1983-08-25 | 1985-09-17 | Penlon Limited | Gas humidifying apparatus and method |
EP0156409A2 (en) * | 1984-02-23 | 1985-10-02 | Jean Michel Anthony | Device for moistening parts of the human body |
US4546768A (en) * | 1981-12-22 | 1985-10-15 | Feierabend Georg | Inhalation apparatus for animals |
EP0186280A2 (en) * | 1984-11-02 | 1986-07-02 | Robert Landis | Breath activated medication spray |
EP0200258A2 (en) * | 1985-04-29 | 1986-11-05 | Jean Michel Anthony | Ultrasonic spraying device |
EP0232235A2 (en) * | 1986-01-27 | 1987-08-12 | A/S GEA Farmaceutisk Fabrik | Medical dosing device for discharge of atomized medicament for inhalation air |
US4776990A (en) * | 1986-11-14 | 1988-10-11 | Rhinotherm Netzer Sereni | Method and apparatus for nebulizing a liquid |
JPS63193564U (en) * | 1987-06-02 | 1988-12-13 | ||
WO1989006147A1 (en) * | 1987-12-31 | 1989-07-13 | Etelä-Hämeen Keuhkovammayhdistys R.Y. | Ultrasonic atomizer |
WO1992011512A1 (en) * | 1990-12-17 | 1992-07-09 | Minnesota Mining And Manufacturing Company | Device for measuring a pre-determined volume of liquid flowing there through |
WO1992011050A1 (en) * | 1990-12-17 | 1992-07-09 | Minnesota Mining And Manufacturing Company | Inhaler |
US5139016A (en) * | 1987-08-07 | 1992-08-18 | Sorin Biomedica S.P.A. | Process and device for aerosol generation for pulmonary ventilation scintigraphy |
US5152456A (en) * | 1989-12-12 | 1992-10-06 | Bespak, Plc | Dispensing apparatus having a perforate outlet member and a vibrating device |
US5221025A (en) * | 1989-05-31 | 1993-06-22 | Conceptair Anstalt | Method and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase |
US5259254A (en) * | 1991-09-25 | 1993-11-09 | Cetac Technologies, Inc. | Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use |
GB2273660A (en) * | 1992-09-11 | 1994-06-29 | Aid Medic Ltd | Nebulizer drug delivery system |
DE4300880A1 (en) * | 1993-01-15 | 1994-07-21 | Draegerwerk Ag | Ultrasonic nebulizer with dosing unit |
EP0642802A2 (en) * | 1993-08-09 | 1995-03-15 | Disetronic Ag | Inhalation device |
US5407424A (en) * | 1993-02-24 | 1995-04-18 | Scimed Life Systems, Inc. | Angioplasty perfusion pump |
WO1996001663A1 (en) * | 1994-07-11 | 1996-01-25 | Aradigm Corporation | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5507277A (en) * | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
WO1996013292A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
WO1996013290A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device for aerosolized delivery of peptide drugs |
WO1996013291A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device for aerosolizing narcotics |
US5518179A (en) * | 1991-12-04 | 1996-05-21 | The Technology Partnership Limited | Fluid droplets production apparatus and method |
US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5529055A (en) * | 1993-06-02 | 1996-06-25 | L'oreal | Piezoelectric nebulizing apparatus |
WO1996028206A1 (en) * | 1995-03-14 | 1996-09-19 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosating unit |
WO1996028205A1 (en) * | 1995-03-14 | 1996-09-19 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosing unit |
WO1996030068A1 (en) * | 1995-03-31 | 1996-10-03 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
WO1996031289A1 (en) | 1993-12-07 | 1996-10-10 | Fluid Propulsion Technologies, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
US5586550A (en) * | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
NL1001682C2 (en) * | 1995-11-17 | 1997-05-21 | R & D Injector Ag | Nebulizer device. |
WO1997031721A1 (en) * | 1996-02-27 | 1997-09-04 | Medix Limited | A nebuliser |
US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5694919A (en) * | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US5709202A (en) * | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
US5743250A (en) * | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
EP0844027A1 (en) * | 1995-08-07 | 1998-05-27 | Omron Corporation | Atomization apparatus and method utilizing surface acoustic waves |
US5758637A (en) * | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5771882A (en) * | 1995-09-12 | 1998-06-30 | Siemens Elema Ab | Anesthetic administration apparatus which delivers anesthetic in microdroplets |
US5792057A (en) * | 1993-05-21 | 1998-08-11 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
US5819726A (en) * | 1993-01-29 | 1998-10-13 | Aradigm Corporation | Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease |
US5826570A (en) * | 1991-03-05 | 1998-10-27 | Aradigm Corporation | Delivery of aerosol medications for inspiration |
US5829436A (en) * | 1996-02-05 | 1998-11-03 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
US5884620A (en) * | 1993-01-29 | 1999-03-23 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US5910301A (en) * | 1994-05-13 | 1999-06-08 | Aradigm Corporation | Method of intrapulmonary administration of a narcotic drug |
US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
US6014970A (en) * | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6024090A (en) * | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US6085740A (en) * | 1996-02-21 | 2000-07-11 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6098620A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US6138668A (en) * | 1991-07-02 | 2000-10-31 | Inhale Therpeutic Systems | Method and device for delivering aerosolized medicaments |
EP1066850A1 (en) * | 1999-07-08 | 2001-01-10 | Siemens-Elema AB | Medical Nebulizer |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
WO2001019437A1 (en) | 1999-09-16 | 2001-03-22 | Instrumentarium Corporation | Nebulizer apparatus |
US6205999B1 (en) | 1995-04-05 | 2001-03-27 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
WO2001032246A1 (en) * | 1999-11-05 | 2001-05-10 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebuliser |
US6235177B1 (en) | 1999-09-09 | 2001-05-22 | Aerogen, Inc. | Method for the construction of an aperture plate for dispensing liquid droplets |
US6260549B1 (en) * | 1998-06-18 | 2001-07-17 | Clavius Devices, Inc. | Breath-activated metered-dose inhaler |
WO2001076762A2 (en) | 2000-04-12 | 2001-10-18 | Instrumentarium Corporation | Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus |
WO2002036269A1 (en) | 2000-10-30 | 2002-05-10 | Instrumentarium Corporation | Device and method for detecting and controlling liquid supply to an apparatus discharging liquid |
EP1219313A1 (en) | 2000-12-29 | 2002-07-03 | Instrumentarium Corporation | Liquid discharging apparatus and magneto-shape-memory type valve |
EP1219314A1 (en) | 2000-12-29 | 2002-07-03 | Instrumentarium Corporation | Liquid discharge apparatus having magnetic valve |
WO2002087772A1 (en) * | 2001-05-02 | 2002-11-07 | Aerogen, Inc. | Cymbal-shaped actuator for a nebulizing element |
US6543443B1 (en) | 2000-07-12 | 2003-04-08 | Aerogen, Inc. | Methods and devices for nebulizing fluids |
US6543448B1 (en) | 1994-09-21 | 2003-04-08 | Inhale Therapeutic Systems, Inc. | Apparatus and methods for dispersing dry powder medicaments |
US6546929B2 (en) | 1998-06-04 | 2003-04-15 | Inhale Therapeutic Systems, Inc. | Dry powder dispersing apparatus and methods for their use |
US6546927B2 (en) | 2001-03-13 | 2003-04-15 | Aerogen, Inc. | Methods and apparatus for controlling piezoelectric vibration |
US20030072717A1 (en) * | 2001-02-23 | 2003-04-17 | Vapotronics, Inc. | Inhalation device having an optimized air flow path |
US6550472B2 (en) | 2001-03-16 | 2003-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids using flow directors |
US6554201B2 (en) | 2001-05-02 | 2003-04-29 | Aerogen, Inc. | Insert molded aerosol generator and methods |
WO2003059423A1 (en) * | 2002-01-15 | 2003-07-24 | Aerogen, Inc. | Systems and methods for clearing aerosols from the effective anatomic dead space |
US20030136402A1 (en) * | 2002-01-09 | 2003-07-24 | Brigham And Women's Hospital, Inc. | Method for altering the body temperature of a patient using a nebulized mist |
US6606989B1 (en) * | 1997-05-16 | 2003-08-19 | Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh | Precise administration of a medicated aerosol via the lungs |
US6629646B1 (en) | 1991-04-24 | 2003-10-07 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US6651650B1 (en) * | 1992-04-09 | 2003-11-25 | Omron Corporation | Ultrasonic atomizer, ultrasonic inhaler and method of controlling same |
US6655376B2 (en) * | 1998-04-21 | 2003-12-02 | Pneumoflex Systems L.L.C. | Aspiration screening process for assessing post surgery patient's risk for pneumonia |
US6679249B2 (en) * | 1998-04-21 | 2004-01-20 | Pneumoflex Systems, L.L.C. | Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US20040039755A1 (en) * | 2002-06-05 | 2004-02-26 | Matthew Kunze | Metadata relationships |
US20040050860A1 (en) * | 2002-05-10 | 2004-03-18 | Crowder Timothy M. | Apparatus, systems and related methods for dispensing and /or evaluating dry powders |
US20040055598A1 (en) * | 2002-05-10 | 2004-03-25 | Crowder Timothy M. | Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders |
US6729334B1 (en) * | 1994-06-17 | 2004-05-04 | Trudell Medical Limited | Nebulizing catheter system and methods of use and manufacture |
US6732944B2 (en) | 2001-05-02 | 2004-05-11 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US20040139968A1 (en) * | 2001-03-20 | 2004-07-22 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US20040153262A1 (en) * | 2002-05-10 | 2004-08-05 | Crowder Timothy M. | Dry powder dose filling systems and related methods |
US6782886B2 (en) | 1995-04-05 | 2004-08-31 | Aerogen, Inc. | Metering pumps for an aerosolizer |
US20040170568A1 (en) * | 1997-09-29 | 2004-09-02 | Weers Jeffry G. | Stabilized preparations for use in metered dose inhalers |
US20040256487A1 (en) * | 2003-05-20 | 2004-12-23 | Collins James F. | Ophthalmic drug delivery system |
WO2005011574A2 (en) * | 2003-07-30 | 2005-02-10 | Coifman Robert E | Microporous membrane nebulizers |
US20050034719A1 (en) * | 2001-10-18 | 2005-02-17 | Franz Feiner | Inhalation therapy apparatus |
US20050042170A1 (en) * | 2003-02-14 | 2005-02-24 | The Brigham And Women's Hospital, Inc. | Method and device for generating mists and medical uses thereof |
US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US20050103337A1 (en) * | 2003-10-27 | 2005-05-19 | Anthony James Hickey | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US20050109659A1 (en) * | 2003-10-27 | 2005-05-26 | Hickey Anthony J. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
US20050125002A1 (en) * | 2003-10-31 | 2005-06-09 | George Baran | System and method for manipulating a catheter for delivering a substance to a body cavity |
US20050133024A1 (en) * | 2003-11-25 | 2005-06-23 | Coifman Robert E. | Devices for measuring inspiratory airflow |
US6948491B2 (en) | 2001-03-20 | 2005-09-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US20050229927A1 (en) * | 2004-04-20 | 2005-10-20 | Aerogen, Inc. | Ventilation systems and methods employing aerosol generators |
US20050267628A1 (en) * | 2002-05-10 | 2005-12-01 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
US20050274377A1 (en) * | 1993-01-29 | 2005-12-15 | Igor Gonda | Method of treating diabetes mellitus in a patient |
US6978779B2 (en) | 2002-04-19 | 2005-12-27 | Instrumentarium Corp. | Vibrating element liquid discharging apparatus having gas pressure sensing |
US20060001952A1 (en) * | 2004-07-02 | 2006-01-05 | Liekki Oy | Method and device for producing optical material, and an optical waveguide |
US7040549B2 (en) | 1991-04-24 | 2006-05-09 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator |
US20060097068A1 (en) * | 2002-08-02 | 2006-05-11 | Markus Urich | Fluid droplet production apparatus and method |
US20060102172A1 (en) * | 2002-10-30 | 2006-05-18 | Pari Gmbh Spezialisten Fur Effektive Inhalation | Inhalation therapy device |
WO2005102431A3 (en) * | 2004-04-20 | 2006-06-22 | Aerogen Inc | Aerosol delivery apparatus for pressure assisted breathing |
US20060164912A1 (en) * | 2002-10-15 | 2006-07-27 | Christophe Arnaud | Method and device for making a dispersion or an emulsion |
US20060237090A1 (en) * | 2003-03-11 | 2006-10-26 | Prolitec, S.A. | Method and device for nebulisation |
US7201167B2 (en) * | 2004-04-20 | 2007-04-10 | Aerogen, Inc. | Method and composition for the treatment of lung surfactant deficiency or dysfunction |
US20070102533A1 (en) * | 1999-06-11 | 2007-05-10 | Aradigm Corporation; Universidad De Sevilla | Aerosol created by directed flow of fluids and devices and methods for producing same |
US20070176017A1 (en) * | 2006-01-30 | 2007-08-02 | Berger Harvey L | Ultrasonic atomizing nozzle and method |
WO2007106386A2 (en) | 2006-03-10 | 2007-09-20 | Aradgim Corporation | Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations |
US7290541B2 (en) * | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US7306787B2 (en) | 1997-09-29 | 2007-12-11 | Nektar Therapeutics | Engineered particles and methods of use |
US7322349B2 (en) * | 2000-05-05 | 2008-01-29 | Aerogen, Inc. | Apparatus and methods for the delivery of medicaments to the respiratory system |
US7331339B2 (en) | 2000-05-05 | 2008-02-19 | Aerogen, Inc. | Methods and systems for operating an aerosol generator |
US20080053431A1 (en) * | 1996-05-13 | 2008-03-06 | The Universidad De Sevilla | Device and method for creating aerosols for drug delivery |
US7360536B2 (en) | 2002-01-07 | 2008-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids for inhalation |
US20080257337A1 (en) * | 2007-04-19 | 2008-10-23 | Denyer Jonathan S H | Ventilator Aerosol Delivery |
US20080308096A1 (en) * | 2005-02-11 | 2008-12-18 | Pari Pharma Gmbh | Aerosol Generating Device and Inhalation Therapy Unit Provided with This Device |
US20090022669A1 (en) * | 2001-05-21 | 2009-01-22 | Vapotronics, Inc. | Compositions for protein delivery via the pulmonary route |
EP2050479A2 (en) * | 2007-10-16 | 2009-04-22 | General Electric Company | Apparatus, system and method for admistering an anesthetic agent for a subject breathing |
EP2050478A1 (en) * | 2007-10-16 | 2009-04-22 | GE Healthcare Finland Oy | Device for delivery and regulation of volatile fluids into inspiratory gas |
US20090107503A1 (en) * | 1994-06-17 | 2009-04-30 | Trudell Medical Limited | Nebulizing catheter system and methods of use and manufacture |
US7600511B2 (en) | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
EP2119465A1 (en) * | 2008-05-16 | 2009-11-18 | Markos Mefar S.P.A. | Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user |
US7628339B2 (en) | 1991-04-24 | 2009-12-08 | Novartis Pharma Ag | Systems and methods for controlling fluid feed to an aerosol generator |
US20090308945A1 (en) * | 2008-06-17 | 2009-12-17 | Jacob Loverich | Liquid dispensing apparatus using a passive liquid metering method |
US7677467B2 (en) * | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
US7771642B2 (en) | 2002-05-20 | 2010-08-10 | Novartis Ag | Methods of making an apparatus for providing aerosol for medical treatment |
WO2010107958A1 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107957A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107952A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107955A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING |
WO2010111497A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111468A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) |
WO2010111471A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111464A1 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111490A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US7971588B2 (en) | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US8012136B2 (en) | 2003-05-20 | 2011-09-06 | Optimyst Systems, Inc. | Ophthalmic fluid delivery device and method of operation |
US8246934B2 (en) | 1997-09-29 | 2012-08-21 | Novartis Ag | Respiratory dispersion for metered dose inhalers comprising perforated microstructures |
WO2012156724A2 (en) | 2011-05-16 | 2012-11-22 | The Technology Partnership Plc | Separable membrane improvements |
US8332020B2 (en) | 2010-02-01 | 2012-12-11 | Proteus Digital Health, Inc. | Two-wrist data gathering system |
US20120318259A1 (en) * | 2010-01-12 | 2012-12-20 | Omega Life Science Ltd. | Method and apparatus for producing fine concentrated aerosol |
US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US8419638B2 (en) | 2007-11-19 | 2013-04-16 | Proteus Digital Health, Inc. | Body-associated fluid transport structure evaluation devices |
US20130108748A1 (en) * | 2011-11-01 | 2013-05-02 | Pepsico., Inc. | Dispensing Nozzle with an Ultrasound Activator |
US20130267864A1 (en) * | 2004-02-20 | 2013-10-10 | Pneumoflex Systems, Llc | Nebulizer with intra-oral vibrating mesh |
US8616195B2 (en) | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication |
US20140034051A1 (en) * | 2004-02-20 | 2014-02-06 | Pneumoflex Systems, Llc | Nebulizer having horizontal venturi |
US20140053835A1 (en) * | 2012-02-16 | 2014-02-27 | Capnia, Inc. | Gas dispenser with diffusing nosepiece |
US8684980B2 (en) | 2010-07-15 | 2014-04-01 | Corinthian Ophthalmic, Inc. | Drop generating device |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US8715623B2 (en) | 2001-12-19 | 2014-05-06 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US8733935B2 (en) | 2010-07-15 | 2014-05-27 | Corinthian Ophthalmic, Inc. | Method and system for performing remote treatment and monitoring |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US9087145B2 (en) | 2010-07-15 | 2015-07-21 | Eyenovia, Inc. | Ophthalmic drug delivery |
US9084566B2 (en) | 2006-07-07 | 2015-07-21 | Proteus Digital Health, Inc. | Smart parenteral administration system |
US9108211B2 (en) | 2005-05-25 | 2015-08-18 | Nektar Therapeutics | Vibration systems and methods |
US9125979B2 (en) | 2007-10-25 | 2015-09-08 | Proteus Digital Health, Inc. | Fluid transfer port information system |
US9532597B2 (en) | 2012-02-22 | 2017-01-03 | Altria Client Services Llc | Electronic smoking article |
WO2017006091A1 (en) | 2015-07-03 | 2017-01-12 | The Technology Partnership Plc | Aerosol apparatus with improved separable membrane |
US20170021114A1 (en) * | 2014-04-03 | 2017-01-26 | Csl Behring Ag | Nebulization of immunoglobulin |
WO2017051181A1 (en) | 2015-09-22 | 2017-03-30 | The Technology Partnership Plc | Liquid nicotine formulation |
WO2017064473A1 (en) | 2015-10-16 | 2017-04-20 | The Technology Partnership Plc | Linear droplet generating device |
WO2017075318A1 (en) * | 2015-10-30 | 2017-05-04 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
WO2017090011A1 (en) * | 2015-11-26 | 2017-06-01 | Ferrari Brands S.R.L. | Device to deliver a substance |
US10052443B2 (en) | 2014-10-13 | 2018-08-21 | Omega Life Science Ltd. | Nebulizers and uses thereof |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
US10195634B2 (en) | 2013-07-09 | 2019-02-05 | The Technology Partnership Plc | Separable membrane improvements |
US10239085B2 (en) | 2015-10-30 | 2019-03-26 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
US10357060B2 (en) | 2016-03-11 | 2019-07-23 | Altria Client Services Llc | E-vaping device cartridge holder |
US10368580B2 (en) | 2016-03-08 | 2019-08-06 | Altria Client Services Llc | Combined cartridge for electronic vaping device |
US10368581B2 (en) | 2016-03-11 | 2019-08-06 | Altria Client Services Llc | Multiple dispersion generator e-vaping device |
US10433580B2 (en) | 2016-03-03 | 2019-10-08 | Altria Client Services Llc | Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge |
US10455863B2 (en) | 2016-03-03 | 2019-10-29 | Altria Client Services Llc | Cartridge for electronic vaping device |
CN110721865A (en) * | 2019-11-07 | 2020-01-24 | 湖南嘉业达电子有限公司 | Atomizing device for atomizing essential oil |
US10583038B2 (en) | 2015-04-10 | 2020-03-10 | Kedalion Therapeutics | Piezoelectric dispenser with replaceable ampoule |
US10624781B2 (en) | 2015-01-12 | 2020-04-21 | Kedalion Therapeutics, Inc. | Micro-droplet delivery device and methods |
US20200129709A1 (en) * | 2018-10-28 | 2020-04-30 | Albert Ky | Wearable inspiration synchronic ultrasonic nebulizer-humidifier device |
US10639194B2 (en) | 2011-12-12 | 2020-05-05 | Eyenovia, Inc. | High modulus polymeric ejector mechanism, ejector device, and methods of use |
US10799652B2 (en) | 2015-01-08 | 2020-10-13 | Convexity Scientific Inc. | Nebulizer device |
US10857311B2 (en) | 2010-01-12 | 2020-12-08 | Omega Life Science Ltd. | Method and apparatus for producing fine concentrated aerosol |
US10888454B2 (en) | 2017-01-20 | 2021-01-12 | Kedalion Therapeutics, Inc. | Piezoelectric fluid dispenser |
US11278448B2 (en) | 2017-12-08 | 2022-03-22 | Kedalion Therapeutics, Inc. | Fluid delivery alignment system |
US11298472B2 (en) * | 2020-04-24 | 2022-04-12 | SOSD Health & Medical Innovations Inc. | Ultrasonic nebulizer |
US11571704B2 (en) | 2015-10-30 | 2023-02-07 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
US11583885B2 (en) | 2015-10-30 | 2023-02-21 | Johnson & Johnson Consumer Inc. | Unit dose aseptic aerosol misting device |
US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
US11925577B2 (en) | 2021-04-16 | 2024-03-12 | Bausch + Lomb Ireland Limted | Hydrodynamically actuated preservative free dispensing system |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2658169A (en) * | 1948-03-18 | 1953-11-03 | Centre Nat Rech Scient | Production of aerosols |
US2949900A (en) * | 1958-06-02 | 1960-08-23 | Albert G Bodine | Sonic liquid sprayer |
US3121534A (en) * | 1960-09-29 | 1964-02-18 | Exxon Research Engineering Co | Supersonic liquid atomizer and electronic oscillator therefor |
US3214101A (en) * | 1964-03-31 | 1965-10-26 | Little Inc A | Apparatus for atomizing a liquid |
US3243122A (en) * | 1965-02-24 | 1966-03-29 | Alvin A Snaper | Ultrasonic spray apparatus |
US3400892A (en) * | 1965-12-02 | 1968-09-10 | Battelle Development Corp | Resonant vibratory apparatus |
US3561444A (en) * | 1968-05-22 | 1971-02-09 | Bio Logics Inc | Ultrasonic drug nebulizer |
US3653379A (en) * | 1970-08-20 | 1972-04-04 | Joseph G Glenn | Adjustable pressure ippb ventilator |
-
1972
- 1972-10-20 US US00299194A patent/US3812854A/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2658169A (en) * | 1948-03-18 | 1953-11-03 | Centre Nat Rech Scient | Production of aerosols |
US2949900A (en) * | 1958-06-02 | 1960-08-23 | Albert G Bodine | Sonic liquid sprayer |
US3121534A (en) * | 1960-09-29 | 1964-02-18 | Exxon Research Engineering Co | Supersonic liquid atomizer and electronic oscillator therefor |
US3214101A (en) * | 1964-03-31 | 1965-10-26 | Little Inc A | Apparatus for atomizing a liquid |
US3243122A (en) * | 1965-02-24 | 1966-03-29 | Alvin A Snaper | Ultrasonic spray apparatus |
US3400892A (en) * | 1965-12-02 | 1968-09-10 | Battelle Development Corp | Resonant vibratory apparatus |
US3561444A (en) * | 1968-05-22 | 1971-02-09 | Bio Logics Inc | Ultrasonic drug nebulizer |
US3653379A (en) * | 1970-08-20 | 1972-04-04 | Joseph G Glenn | Adjustable pressure ippb ventilator |
Cited By (388)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3912168A (en) * | 1975-01-30 | 1975-10-14 | Teledyne Ind Inc Teledyne Aqua | Irrigation lavage |
US4119096A (en) * | 1975-08-25 | 1978-10-10 | Siemens Aktiengesellschaft | Medical inhalation device for the treatment of diseases of the respiratory tract |
US4106503A (en) * | 1977-03-11 | 1978-08-15 | Richard R. Rosenthal | Metering system for stimulating bronchial spasm |
US4109863A (en) * | 1977-08-17 | 1978-08-29 | The United States Of America As Represented By The United States Department Of Energy | Apparatus for ultrasonic nebulization |
US4292973A (en) * | 1977-09-25 | 1981-10-06 | Kabushiki Kaisha Kurio-Medikaru | Apparatus for refrigeration treatment |
US4348873A (en) * | 1977-09-25 | 1982-09-14 | Kabushiki Kaisha Kurio-Medikaru | Apparatus for refrigeration treatment |
US4412538A (en) * | 1977-09-25 | 1983-11-01 | Kabushiki Kaisha Kurio-Medikaru | Apparatus for refrigeration treatment |
US4261512A (en) * | 1979-02-24 | 1981-04-14 | Boehringer Ingelheim Gmbh | Inhalation aerosol spray device |
US4546768A (en) * | 1981-12-22 | 1985-10-15 | Feierabend Georg | Inhalation apparatus for animals |
US4541966A (en) * | 1983-08-25 | 1985-09-17 | Penlon Limited | Gas humidifying apparatus and method |
EP0156409A2 (en) * | 1984-02-23 | 1985-10-02 | Jean Michel Anthony | Device for moistening parts of the human body |
EP0156409A3 (en) * | 1984-02-23 | 1986-06-25 | Jean Michel Anthony | Device for moistening parts of the human body |
US4648393A (en) * | 1984-11-02 | 1987-03-10 | Ackrad Laboratories, Inc. | Breath activated medication spray |
EP0186280A2 (en) * | 1984-11-02 | 1986-07-02 | Robert Landis | Breath activated medication spray |
EP0186280A3 (en) * | 1984-11-02 | 1988-01-13 | Robert Landis | Breath activated medication spray |
US4815661A (en) * | 1985-04-29 | 1989-03-28 | Tomtec N.V. | Ultrasonic spraying device |
EP0200258A2 (en) * | 1985-04-29 | 1986-11-05 | Jean Michel Anthony | Ultrasonic spraying device |
EP0200258A3 (en) * | 1985-04-29 | 1988-02-03 | Jean Michel Anthony | Ultrasonic spraying device |
EP0232235A3 (en) * | 1986-01-27 | 1989-05-03 | A/S GEA Farmaceutisk Fabrik | Medical dosing device for discharge of atomized medicament for inhalation air |
EP0232235A2 (en) * | 1986-01-27 | 1987-08-12 | A/S GEA Farmaceutisk Fabrik | Medical dosing device for discharge of atomized medicament for inhalation air |
US4776990A (en) * | 1986-11-14 | 1988-10-11 | Rhinotherm Netzer Sereni | Method and apparatus for nebulizing a liquid |
JPS63193564U (en) * | 1987-06-02 | 1988-12-13 | ||
JPH0545407Y2 (en) * | 1987-06-02 | 1993-11-19 | ||
US5139016A (en) * | 1987-08-07 | 1992-08-18 | Sorin Biomedica S.P.A. | Process and device for aerosol generation for pulmonary ventilation scintigraphy |
WO1989006147A1 (en) * | 1987-12-31 | 1989-07-13 | Etelä-Hämeen Keuhkovammayhdistys R.Y. | Ultrasonic atomizer |
GB2219512A (en) * | 1987-12-31 | 1989-12-13 | Etelae Haemeen Keuhkovammayhdi | Ultrasonic atomizer |
GB2219512B (en) * | 1987-12-31 | 1991-09-04 | Etelae Haemeen Keuhkovammayhdi | Ultrasonic atomizer |
US5063922A (en) * | 1987-12-31 | 1991-11-12 | Etala-Hameen Keuhkovammayhdistys R.Y. | Ultrasonic atomizer |
US5221025A (en) * | 1989-05-31 | 1993-06-22 | Conceptair Anstalt | Method and mechanical, electrical, or electronic apparatus for dispensing, issuing, or diffusing medicines, fragrances or other liquid or visous substances in the liquid phase or in the gaseous phase |
US5261601A (en) * | 1989-12-12 | 1993-11-16 | Bespak Plc | Liquid dispensing apparatus having a vibrating perforate membrane |
US5152456A (en) * | 1989-12-12 | 1992-10-06 | Bespak, Plc | Dispensing apparatus having a perforate outlet member and a vibrating device |
WO1992011512A1 (en) * | 1990-12-17 | 1992-07-09 | Minnesota Mining And Manufacturing Company | Device for measuring a pre-determined volume of liquid flowing there through |
US5392648A (en) * | 1990-12-17 | 1995-02-28 | Minnesota Mining And Manufacturing Company | Device for measuring a pre-determined volume of liquid flowing therethrough |
WO1992011050A1 (en) * | 1990-12-17 | 1992-07-09 | Minnesota Mining And Manufacturing Company | Inhaler |
US5487378A (en) * | 1990-12-17 | 1996-01-30 | Minnesota Mining And Manufacturing Company | Inhaler |
US5826570A (en) * | 1991-03-05 | 1998-10-27 | Aradigm Corporation | Delivery of aerosol medications for inspiration |
US7083112B2 (en) | 1991-04-24 | 2006-08-01 | Aerogen, Inc. | Method and apparatus for dispensing liquids as an atomized spray |
US7628339B2 (en) | 1991-04-24 | 2009-12-08 | Novartis Pharma Ag | Systems and methods for controlling fluid feed to an aerosol generator |
US5938117A (en) * | 1991-04-24 | 1999-08-17 | Aerogen, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
US6540153B1 (en) | 1991-04-24 | 2003-04-01 | Aerogen, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
US20070075161A1 (en) * | 1991-04-24 | 2007-04-05 | Aerogen, Inc. | Droplet Ejector With Oscillating Tapered Aperture |
US7108197B2 (en) * | 1991-04-24 | 2006-09-19 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US20050279851A1 (en) * | 1991-04-24 | 2005-12-22 | Aerogen, Inc. | Method and apparatus for dispensing liquids as an atomized spray |
US6629646B1 (en) | 1991-04-24 | 2003-10-07 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US20030226906A1 (en) * | 1991-04-24 | 2003-12-11 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US7040549B2 (en) | 1991-04-24 | 2006-05-09 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator |
US20050263608A1 (en) * | 1991-04-24 | 2005-12-01 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US6926208B2 (en) | 1991-04-24 | 2005-08-09 | Aerogen, Inc. | Droplet ejector with oscillating tapered aperture |
US6138668A (en) * | 1991-07-02 | 2000-10-31 | Inhale Therpeutic Systems | Method and device for delivering aerosolized medicaments |
US20050279349A1 (en) * | 1991-07-02 | 2005-12-22 | Patton John S | Method and device for delivering aerosolized medicaments |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US5259254A (en) * | 1991-09-25 | 1993-11-09 | Cetac Technologies, Inc. | Sample introduction system for inductively coupled plasma and other gas-phase, or particle, detectors utilizing ultrasonic nebulization, and method of use |
US5518179A (en) * | 1991-12-04 | 1996-05-21 | The Technology Partnership Limited | Fluid droplets production apparatus and method |
US6651650B1 (en) * | 1992-04-09 | 2003-11-25 | Omron Corporation | Ultrasonic atomizer, ultrasonic inhaler and method of controlling same |
GB2273660B (en) * | 1992-09-11 | 1996-07-17 | Aid Medic Ltd | Drug delivery arrangement |
US6116233A (en) * | 1992-09-11 | 2000-09-12 | Medic-Aid Limited | Drug delivery arrangement |
GB2273660A (en) * | 1992-09-11 | 1994-06-29 | Aid Medic Ltd | Nebulizer drug delivery system |
DE4300880A1 (en) * | 1993-01-15 | 1994-07-21 | Draegerwerk Ag | Ultrasonic nebulizer with dosing unit |
US5443059A (en) * | 1993-01-15 | 1995-08-22 | Dragerwerk Ag | Ultrasonic atomizer with a metering unit |
US5819726A (en) * | 1993-01-29 | 1998-10-13 | Aradigm Corporation | Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease |
US20090241950A1 (en) * | 1993-01-29 | 2009-10-01 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
US7490603B2 (en) * | 1993-01-29 | 2009-02-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US6024090A (en) * | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US7021309B2 (en) * | 1993-01-29 | 2006-04-04 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5694919A (en) * | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US7028686B2 (en) * | 1993-01-29 | 2006-04-18 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US20040089290A1 (en) * | 1993-01-29 | 2004-05-13 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US5724957A (en) * | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
US20080264416A1 (en) * | 1993-01-29 | 2008-10-30 | Novo Nordisk A/S | Method of Treating Diabetes Mellitus in a Patient |
US20040062722A1 (en) * | 1993-01-29 | 2004-04-01 | Igor Gonda | Method of use of monomeric insulin as a means for improving the reproducibilty of inhaled insulin |
US6431167B1 (en) * | 1993-01-29 | 2002-08-13 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US6688304B2 (en) * | 1993-01-29 | 2004-02-10 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US20060093556A1 (en) * | 1993-01-29 | 2006-05-04 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5507277A (en) * | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
US6085753A (en) * | 1993-01-29 | 2000-07-11 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US6647987B2 (en) | 1993-01-29 | 2003-11-18 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US20060124125A1 (en) * | 1993-01-29 | 2006-06-15 | Igor Gonda | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
US5735263A (en) * | 1993-01-29 | 1998-04-07 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US20080099010A1 (en) * | 1993-01-29 | 2008-05-01 | Igor Gonda | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5743250A (en) * | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
US5884620A (en) * | 1993-01-29 | 1999-03-23 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US6431166B2 (en) | 1993-01-29 | 2002-08-13 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US6427681B1 (en) | 1993-01-29 | 2002-08-06 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US6408854B1 (en) | 1993-01-29 | 2002-06-25 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
US6250298B1 (en) | 1993-01-29 | 2001-06-26 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US20080099011A1 (en) * | 1993-01-29 | 2008-05-01 | Novo Nordisk | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US5941240A (en) * | 1993-01-29 | 1999-08-24 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US6167880B1 (en) | 1993-01-29 | 2001-01-02 | Aradigm Corporation | Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
US5558085A (en) * | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5960792A (en) * | 1993-01-29 | 1999-10-05 | Aradigm Corporation | Device for aerosolized delivery of peptide drugs |
US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
US20050274377A1 (en) * | 1993-01-29 | 2005-12-15 | Igor Gonda | Method of treating diabetes mellitus in a patient |
US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
US6098615A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Method of reproducibly effecting a patient's glucose level |
US6098620A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
US5407424A (en) * | 1993-02-24 | 1995-04-18 | Scimed Life Systems, Inc. | Angioplasty perfusion pump |
US5544646A (en) * | 1993-05-21 | 1996-08-13 | Aradigm Corporation | Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
US5823178A (en) * | 1993-05-21 | 1998-10-20 | Aradigm Corporation | Disposable package for use in aerosolized delivery of drugs |
US6014969A (en) * | 1993-05-21 | 2000-01-18 | Aradigm Corporation | Disposable package for use in aerosolized delivery of antibiotics |
US5792057A (en) * | 1993-05-21 | 1998-08-11 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
US5718222A (en) * | 1993-05-21 | 1998-02-17 | Aradigm Corporation | Disposable package for use in aerosolized delivery of drugs |
US6123068A (en) * | 1993-05-21 | 2000-09-26 | Aradigm Corporation | Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
US5709202A (en) * | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
AU690561B2 (en) * | 1993-05-21 | 1998-04-30 | Aradigm Corporation | The intrapulmonary delivery of aerosolized aqueous formulations |
US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5660166A (en) * | 1993-05-21 | 1997-08-26 | Aradigm Corporation | Systems for the intrapulmonary delivery of aerosolized aqueous formulations |
US5529055A (en) * | 1993-06-02 | 1996-06-25 | L'oreal | Piezoelectric nebulizing apparatus |
EP0642802A3 (en) * | 1993-08-09 | 1996-03-13 | Disetronic Ag | Inhalation device. |
EP0642802A2 (en) * | 1993-08-09 | 1995-03-15 | Disetronic Ag | Inhalation device |
WO1996031289A1 (en) | 1993-12-07 | 1996-10-10 | Fluid Propulsion Technologies, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
US5910301A (en) * | 1994-05-13 | 1999-06-08 | Aradigm Corporation | Method of intrapulmonary administration of a narcotic drug |
US7469700B2 (en) | 1994-06-17 | 2008-12-30 | Trudell Medical Limited | Nebulizing catheter system for delivering an aerosol to a patient |
US6729334B1 (en) * | 1994-06-17 | 2004-05-04 | Trudell Medical Limited | Nebulizing catheter system and methods of use and manufacture |
US7472705B2 (en) | 1994-06-17 | 2009-01-06 | Trudell Medical Limited | Methods of forming a nebulizing catheter |
US20090107503A1 (en) * | 1994-06-17 | 2009-04-30 | Trudell Medical Limited | Nebulizing catheter system and methods of use and manufacture |
WO1996001663A1 (en) * | 1994-07-11 | 1996-01-25 | Aradigm Corporation | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
US5509404A (en) * | 1994-07-11 | 1996-04-23 | Aradigm Corporation | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
EP1310268A3 (en) * | 1994-07-11 | 2003-11-26 | Aradigm Corporation | Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
US6543448B1 (en) | 1994-09-21 | 2003-04-08 | Inhale Therapeutic Systems, Inc. | Apparatus and methods for dispersing dry powder medicaments |
US5957124A (en) * | 1994-09-27 | 1999-09-28 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
JPH11508456A (en) * | 1994-10-28 | 1999-07-27 | アラディグム コーポレーション | Device to convert anesthetic into aerosol |
AU709572B2 (en) * | 1994-10-28 | 1999-09-02 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
AU708150B2 (en) * | 1994-10-28 | 1999-07-29 | Aradigm Corporation | Device for aerosolizing narcotics |
JPH10508230A (en) * | 1994-10-28 | 1998-08-18 | アラディグム コーポレーション | Apparatus and method for producing aerosolized sprays of respiratory drugs |
WO1996013290A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device for aerosolized delivery of peptide drugs |
AU708269B2 (en) * | 1994-10-28 | 1999-07-29 | Aradigm Corporation | Device for aerosolized delivery of peptide drugs |
WO1996013291A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device for aerosolizing narcotics |
WO1996013292A1 (en) * | 1994-10-28 | 1996-05-09 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
AU690438B2 (en) * | 1995-03-14 | 1998-04-23 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosating unit |
WO1996028206A1 (en) * | 1995-03-14 | 1996-09-19 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosating unit |
US5950619A (en) * | 1995-03-14 | 1999-09-14 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosating unit |
WO1996028205A1 (en) * | 1995-03-14 | 1996-09-19 | Siemens Aktiengesellschaft | Ultrasonic atomizer device with removable precision dosing unit |
US5970974A (en) * | 1995-03-14 | 1999-10-26 | Siemens Aktiengesellschaft | Dosating unit for an ultrasonic atomizer device |
WO1996030068A1 (en) * | 1995-03-31 | 1996-10-03 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
US20070209659A1 (en) * | 1995-04-05 | 2007-09-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6467476B1 (en) | 1995-04-05 | 2002-10-22 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US8561604B2 (en) | 1995-04-05 | 2013-10-22 | Novartis Ag | Liquid dispensing apparatus and methods |
US7174888B2 (en) | 1995-04-05 | 2007-02-13 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6755189B2 (en) | 1995-04-05 | 2004-06-29 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6205999B1 (en) | 1995-04-05 | 2001-03-27 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6640804B2 (en) | 1995-04-05 | 2003-11-04 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6782886B2 (en) | 1995-04-05 | 2004-08-31 | Aerogen, Inc. | Metering pumps for an aerosolizer |
EP0844027A4 (en) * | 1995-08-07 | 2001-06-13 | Omron Tateisi Electronics Co | Atomization apparatus and method utilizing surface acoustic waves |
EP0844027A1 (en) * | 1995-08-07 | 1998-05-27 | Omron Corporation | Atomization apparatus and method utilizing surface acoustic waves |
US5586550A (en) * | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
US5758637A (en) * | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5771882A (en) * | 1995-09-12 | 1998-06-30 | Siemens Elema Ab | Anesthetic administration apparatus which delivers anesthetic in microdroplets |
NL1001682C2 (en) * | 1995-11-17 | 1997-05-21 | R & D Injector Ag | Nebulizer device. |
WO1997018846A1 (en) * | 1995-11-17 | 1997-05-29 | R + D Injector Ag | Nebulizing device |
US5829436A (en) * | 1996-02-05 | 1998-11-03 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
US6085740A (en) * | 1996-02-21 | 2000-07-11 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
WO1997031721A1 (en) * | 1996-02-27 | 1997-09-04 | Medix Limited | A nebuliser |
US8733343B2 (en) * | 1996-05-13 | 2014-05-27 | Universidad De Sevilla | Device and method for creating aerosols for drug delivery |
US20080053431A1 (en) * | 1996-05-13 | 2008-03-06 | The Universidad De Sevilla | Device and method for creating aerosols for drug delivery |
US6606989B1 (en) * | 1997-05-16 | 2003-08-19 | Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh | Precise administration of a medicated aerosol via the lungs |
US20040170568A1 (en) * | 1997-09-29 | 2004-09-02 | Weers Jeffry G. | Stabilized preparations for use in metered dose inhalers |
US7306787B2 (en) | 1997-09-29 | 2007-12-11 | Nektar Therapeutics | Engineered particles and methods of use |
US8246934B2 (en) | 1997-09-29 | 2012-08-21 | Novartis Ag | Respiratory dispersion for metered dose inhalers comprising perforated microstructures |
US9554993B2 (en) | 1997-09-29 | 2017-01-31 | Novartis Ag | Pulmonary delivery particles comprising an active agent |
US7628978B2 (en) | 1997-09-29 | 2009-12-08 | Novartis Pharma Ag | Stabilized preparations for use in metered dose inhalers |
US8168223B1 (en) | 1997-09-29 | 2012-05-01 | Novartis Pharma Ag | Engineered particles and methods of use |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
US6655376B2 (en) * | 1998-04-21 | 2003-12-02 | Pneumoflex Systems L.L.C. | Aspiration screening process for assessing post surgery patient's risk for pneumonia |
US6679249B2 (en) * | 1998-04-21 | 2004-01-20 | Pneumoflex Systems, L.L.C. | Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
US8161969B2 (en) | 1998-06-04 | 2012-04-24 | Novartis Ag | Dry powder dispersing apparatus and methods for their use |
US20030209243A1 (en) * | 1998-06-04 | 2003-11-13 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US7422013B2 (en) | 1998-06-04 | 2008-09-09 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US6546929B2 (en) | 1998-06-04 | 2003-04-15 | Inhale Therapeutic Systems, Inc. | Dry powder dispersing apparatus and methods for their use |
US6901929B2 (en) | 1998-06-04 | 2005-06-07 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US20080230058A1 (en) * | 1998-06-04 | 2008-09-25 | Nektar Therapeutics | Dry powder dispersing apparatus and methods for their use |
US8578931B2 (en) | 1998-06-11 | 2013-11-12 | Novartis Ag | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6014970A (en) * | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6318361B1 (en) * | 1998-06-18 | 2001-11-20 | Clavius Devices Inc. | Breath-activated metered-dose inhaler |
US6260549B1 (en) * | 1998-06-18 | 2001-07-17 | Clavius Devices, Inc. | Breath-activated metered-dose inhaler |
US20080053436A1 (en) * | 1999-06-11 | 2008-03-06 | Aradigm Corporation | Aerosol created by directed flow of fluids and devices and methods for producing same |
US20070102533A1 (en) * | 1999-06-11 | 2007-05-10 | Aradigm Corporation; Universidad De Sevilla | Aerosol created by directed flow of fluids and devices and methods for producing same |
US6598602B1 (en) | 1999-07-08 | 2003-07-29 | Siemens-Elema Ab | Medical nebulizer |
EP1066850A1 (en) * | 1999-07-08 | 2001-01-10 | Siemens-Elema AB | Medical Nebulizer |
US8398001B2 (en) | 1999-09-09 | 2013-03-19 | Novartis Ag | Aperture plate and methods for its construction and use |
US20070023547A1 (en) * | 1999-09-09 | 2007-02-01 | Aerogen, Inc. | Aperture plate and methods for its construction and use |
US7066398B2 (en) | 1999-09-09 | 2006-06-27 | Aerogen, Inc. | Aperture plate and methods for its construction and use |
US6235177B1 (en) | 1999-09-09 | 2001-05-22 | Aerogen, Inc. | Method for the construction of an aperture plate for dispensing liquid droplets |
US6530370B1 (en) | 1999-09-16 | 2003-03-11 | Instrumentation Corp. | Nebulizer apparatus |
WO2001019437A1 (en) | 1999-09-16 | 2001-03-22 | Instrumentarium Corporation | Nebulizer apparatus |
EP1227856A1 (en) * | 1999-11-05 | 2002-08-07 | PARI GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
WO2001032246A1 (en) * | 1999-11-05 | 2001-05-10 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebuliser |
EP1227856A4 (en) * | 1999-11-05 | 2007-01-03 | Pari Gmbh | Inhalation nebulizer |
US6539937B1 (en) | 2000-04-12 | 2003-04-01 | Instrumentarium Corp. | Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus |
WO2001076762A2 (en) | 2000-04-12 | 2001-10-18 | Instrumentarium Corporation | Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus |
US7322349B2 (en) * | 2000-05-05 | 2008-01-29 | Aerogen, Inc. | Apparatus and methods for the delivery of medicaments to the respiratory system |
US7971588B2 (en) | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US7748377B2 (en) | 2000-05-05 | 2010-07-06 | Novartis Ag | Methods and systems for operating an aerosol generator |
US7331339B2 (en) | 2000-05-05 | 2008-02-19 | Aerogen, Inc. | Methods and systems for operating an aerosol generator |
US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US9439862B2 (en) | 2000-05-10 | 2016-09-13 | Novartis Ag | Phospholipid-based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US8709484B2 (en) | 2000-05-10 | 2014-04-29 | Novartis Ag | Phospholipid-based powders for drug delivery |
US8349294B2 (en) | 2000-05-10 | 2013-01-08 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US8877162B2 (en) | 2000-05-10 | 2014-11-04 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
US6543443B1 (en) | 2000-07-12 | 2003-04-08 | Aerogen, Inc. | Methods and devices for nebulizing fluids |
US6769626B1 (en) | 2000-10-30 | 2004-08-03 | Instrumentarium Corp. | Device and method for detecting and controlling liquid supply to an apparatus discharging liquids |
WO2002036269A1 (en) | 2000-10-30 | 2002-05-10 | Instrumentarium Corporation | Device and method for detecting and controlling liquid supply to an apparatus discharging liquid |
EP1219314A1 (en) | 2000-12-29 | 2002-07-03 | Instrumentarium Corporation | Liquid discharge apparatus having magnetic valve |
EP1219313A1 (en) | 2000-12-29 | 2002-07-03 | Instrumentarium Corporation | Liquid discharging apparatus and magneto-shape-memory type valve |
US8201554B2 (en) | 2001-02-23 | 2012-06-19 | Injet Digital Aerosols Limited | Inhalation device having an optimized air flow path |
US20030072717A1 (en) * | 2001-02-23 | 2003-04-17 | Vapotronics, Inc. | Inhalation device having an optimized air flow path |
US20090173341A1 (en) * | 2001-02-23 | 2009-07-09 | Injet Digital Aerosols Limited | Inhalation device having an optimized air flow path |
US6546927B2 (en) | 2001-03-13 | 2003-04-15 | Aerogen, Inc. | Methods and apparatus for controlling piezoelectric vibration |
US6550472B2 (en) | 2001-03-16 | 2003-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids using flow directors |
US6948491B2 (en) | 2001-03-20 | 2005-09-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US7195011B2 (en) | 2001-03-20 | 2007-03-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
US8196573B2 (en) | 2001-03-20 | 2012-06-12 | Novartis Ag | Methods and systems for operating an aerosol generator |
US20040139968A1 (en) * | 2001-03-20 | 2004-07-22 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US7032590B2 (en) | 2001-03-20 | 2006-04-25 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US7100600B2 (en) | 2001-03-20 | 2006-09-05 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
US6978941B2 (en) | 2001-05-02 | 2005-12-27 | Aerogen, Inc. | Base isolated nebulizing device and methods |
WO2002087772A1 (en) * | 2001-05-02 | 2002-11-07 | Aerogen, Inc. | Cymbal-shaped actuator for a nebulizing element |
US6554201B2 (en) | 2001-05-02 | 2003-04-29 | Aerogen, Inc. | Insert molded aerosol generator and methods |
US6732944B2 (en) | 2001-05-02 | 2004-05-11 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US7104463B2 (en) | 2001-05-02 | 2006-09-12 | Aerogen, Inc. | Base isolated nebulizing device and methods |
US20090022669A1 (en) * | 2001-05-21 | 2009-01-22 | Vapotronics, Inc. | Compositions for protein delivery via the pulmonary route |
US20050034719A1 (en) * | 2001-10-18 | 2005-02-17 | Franz Feiner | Inhalation therapy apparatus |
US7600511B2 (en) | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
US9421166B2 (en) | 2001-12-19 | 2016-08-23 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US8715623B2 (en) | 2001-12-19 | 2014-05-06 | Novartis Ag | Pulmonary delivery of aminoglycoside |
US7677467B2 (en) * | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament |
US7360536B2 (en) | 2002-01-07 | 2008-04-22 | Aerogen, Inc. | Devices and methods for nebulizing fluids for inhalation |
US8539944B2 (en) | 2002-01-07 | 2013-09-24 | Novartis Ag | Devices and methods for nebulizing fluids for inhalation |
US20030136402A1 (en) * | 2002-01-09 | 2003-07-24 | Brigham And Women's Hospital, Inc. | Method for altering the body temperature of a patient using a nebulized mist |
US7201163B2 (en) * | 2002-01-09 | 2007-04-10 | The Brigham And Women's Hospital, Inc. | Method for altering the body temperature of a patient using a nebulized mist |
WO2003059423A1 (en) * | 2002-01-15 | 2003-07-24 | Aerogen, Inc. | Systems and methods for clearing aerosols from the effective anatomic dead space |
US6845770B2 (en) | 2002-01-15 | 2005-01-25 | Aerogen, Inc. | Systems and methods for clearing aerosols from the effective anatomic dead space |
US6978779B2 (en) | 2002-04-19 | 2005-12-27 | Instrumentarium Corp. | Vibrating element liquid discharging apparatus having gas pressure sensing |
US20050267628A1 (en) * | 2002-05-10 | 2005-12-01 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
US7118010B2 (en) | 2002-05-10 | 2006-10-10 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for dispensing and /or evaluating dry powders |
US20040055598A1 (en) * | 2002-05-10 | 2004-03-25 | Crowder Timothy M. | Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders |
US7428446B2 (en) | 2002-05-10 | 2008-09-23 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
US7677411B2 (en) | 2002-05-10 | 2010-03-16 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders |
US6985798B2 (en) | 2002-05-10 | 2006-01-10 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US20040153262A1 (en) * | 2002-05-10 | 2004-08-05 | Crowder Timothy M. | Dry powder dose filling systems and related methods |
US20050126569A1 (en) * | 2002-05-10 | 2005-06-16 | Crowder Timothy M. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US7520278B2 (en) | 2002-05-10 | 2009-04-21 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US20040050860A1 (en) * | 2002-05-10 | 2004-03-18 | Crowder Timothy M. | Apparatus, systems and related methods for dispensing and /or evaluating dry powders |
US7771642B2 (en) | 2002-05-20 | 2010-08-10 | Novartis Ag | Methods of making an apparatus for providing aerosol for medical treatment |
US20040039755A1 (en) * | 2002-06-05 | 2004-02-26 | Matthew Kunze | Metadata relationships |
US20060097068A1 (en) * | 2002-08-02 | 2006-05-11 | Markus Urich | Fluid droplet production apparatus and method |
US7931212B2 (en) | 2002-08-02 | 2011-04-26 | Pari Pharma Gmbh | Fluid droplet production apparatus and method |
US20110155768A1 (en) * | 2002-08-02 | 2011-06-30 | Pari Pharma Gmbh | Fluid droplet production apparatus and method |
US8511581B2 (en) | 2002-08-02 | 2013-08-20 | Pari Pharma Gmbh | Fluid droplet production apparatus and method |
US7622510B2 (en) * | 2002-10-15 | 2009-11-24 | Christophe Arnaud | Method and device for making a dispersion or an emulsion |
US20060164912A1 (en) * | 2002-10-15 | 2006-07-27 | Christophe Arnaud | Method and device for making a dispersion or an emulsion |
US7458372B2 (en) | 2002-10-30 | 2008-12-02 | Pari Pharma Gmbh | Inhalation therapy device |
US20060102172A1 (en) * | 2002-10-30 | 2006-05-18 | Pari Gmbh Spezialisten Fur Effektive Inhalation | Inhalation therapy device |
US20050042170A1 (en) * | 2003-02-14 | 2005-02-24 | The Brigham And Women's Hospital, Inc. | Method and device for generating mists and medical uses thereof |
US20060237090A1 (en) * | 2003-03-11 | 2006-10-26 | Prolitec, S.A. | Method and device for nebulisation |
US8545463B2 (en) | 2003-05-20 | 2013-10-01 | Optimyst Systems Inc. | Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device |
US8012136B2 (en) | 2003-05-20 | 2011-09-06 | Optimyst Systems, Inc. | Ophthalmic fluid delivery device and method of operation |
US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
US8936021B2 (en) | 2003-05-20 | 2015-01-20 | Optimyst Systems, Inc. | Ophthalmic fluid delivery system |
US20040256487A1 (en) * | 2003-05-20 | 2004-12-23 | Collins James F. | Ophthalmic drug delivery system |
US8616195B2 (en) | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication |
WO2005011574A2 (en) * | 2003-07-30 | 2005-02-10 | Coifman Robert E | Microporous membrane nebulizers |
WO2005011574A3 (en) * | 2003-07-30 | 2005-10-20 | Robert E Coifman | Microporous membrane nebulizers |
US7377277B2 (en) | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
US20050109659A1 (en) * | 2003-10-27 | 2005-05-26 | Hickey Anthony J. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
US20080197044A1 (en) * | 2003-10-27 | 2008-08-21 | Oriel Therapeutics, Inc. | Blister packages with frames for dry powder drug containment |
US7451761B2 (en) | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US20050103337A1 (en) * | 2003-10-27 | 2005-05-19 | Anthony James Hickey | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US7914517B2 (en) | 2003-10-31 | 2011-03-29 | Trudell Medical International | System and method for manipulating a catheter for delivering a substance to a body cavity |
US20050125002A1 (en) * | 2003-10-31 | 2005-06-09 | George Baran | System and method for manipulating a catheter for delivering a substance to a body cavity |
EP1694392A4 (en) * | 2003-11-25 | 2008-05-14 | Robert E Coifman | Devices for measuring inspiratory airflow |
WO2005051177A3 (en) * | 2003-11-25 | 2006-03-16 | Robert E Coifman | Devices for measuring inspiratory airflow |
EP1694392A2 (en) * | 2003-11-25 | 2006-08-30 | Robert E. Coifman | Devices for measuring inspiratory airflow |
US20050133024A1 (en) * | 2003-11-25 | 2005-06-23 | Coifman Robert E. | Devices for measuring inspiratory airflow |
US20140034051A1 (en) * | 2004-02-20 | 2014-02-06 | Pneumoflex Systems, Llc | Nebulizer having horizontal venturi |
US9227029B2 (en) * | 2004-02-20 | 2016-01-05 | Pneumoflex Systems, Llc | Nebulizer having horizontal venturi |
US20130267864A1 (en) * | 2004-02-20 | 2013-10-10 | Pneumoflex Systems, Llc | Nebulizer with intra-oral vibrating mesh |
US9022027B2 (en) * | 2004-02-20 | 2015-05-05 | Pneumoflex Systems, Llc | Nebulizer with intra-oral vibrating mesh |
US20050229927A1 (en) * | 2004-04-20 | 2005-10-20 | Aerogen, Inc. | Ventilation systems and methods employing aerosol generators |
WO2005102431A3 (en) * | 2004-04-20 | 2006-06-22 | Aerogen Inc | Aerosol delivery apparatus for pressure assisted breathing |
US7201167B2 (en) * | 2004-04-20 | 2007-04-10 | Aerogen, Inc. | Method and composition for the treatment of lung surfactant deficiency or dysfunction |
US7267121B2 (en) * | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US7946291B2 (en) * | 2004-04-20 | 2011-05-24 | Novartis Ag | Ventilation systems and methods employing aerosol generators |
US7290541B2 (en) * | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
US20060001952A1 (en) * | 2004-07-02 | 2006-01-05 | Liekki Oy | Method and device for producing optical material, and an optical waveguide |
US20080308096A1 (en) * | 2005-02-11 | 2008-12-18 | Pari Pharma Gmbh | Aerosol Generating Device and Inhalation Therapy Unit Provided with This Device |
US9027548B2 (en) * | 2005-02-11 | 2015-05-12 | Pari Pharma Gmbh | Aerosol generating device and inhalation therapy unit provided with this device |
US9108211B2 (en) | 2005-05-25 | 2015-08-18 | Nektar Therapeutics | Vibration systems and methods |
US7712680B2 (en) * | 2006-01-30 | 2010-05-11 | Sono-Tek Corporation | Ultrasonic atomizing nozzle and method |
US20070176017A1 (en) * | 2006-01-30 | 2007-08-02 | Berger Harvey L | Ultrasonic atomizing nozzle and method |
US20070256684A1 (en) * | 2006-03-10 | 2007-11-08 | Aradigm Corporation | Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations |
WO2007106386A2 (en) | 2006-03-10 | 2007-09-20 | Aradgim Corporation | Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations |
US7958887B2 (en) | 2006-03-10 | 2011-06-14 | Aradigm Corporation | Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations |
US9084566B2 (en) | 2006-07-07 | 2015-07-21 | Proteus Digital Health, Inc. | Smart parenteral administration system |
US8371299B2 (en) | 2007-04-19 | 2013-02-12 | Respironics Respiratory Drug Delivery | Ventilator aerosol delivery |
US20080257337A1 (en) * | 2007-04-19 | 2008-10-23 | Denyer Jonathan S H | Ventilator Aerosol Delivery |
US8371290B2 (en) | 2007-10-16 | 2013-02-12 | General Electric Company | Device for delivery and regulation of volatile fluids into inspiratory gas |
EP2050479A3 (en) * | 2007-10-16 | 2013-06-19 | General Electric Company | Apparatus, system and method for admistering an anesthetic agent for a subject breathing |
US20090288659A1 (en) * | 2007-10-16 | 2009-11-26 | Heikki Haveri | Apparatus, system and method for administering an anesthetic agent for a subject breathing |
EP2050478A1 (en) * | 2007-10-16 | 2009-04-22 | GE Healthcare Finland Oy | Device for delivery and regulation of volatile fluids into inspiratory gas |
EP2050479A2 (en) * | 2007-10-16 | 2009-04-22 | General Electric Company | Apparatus, system and method for admistering an anesthetic agent for a subject breathing |
US9125979B2 (en) | 2007-10-25 | 2015-09-08 | Proteus Digital Health, Inc. | Fluid transfer port information system |
US8419638B2 (en) | 2007-11-19 | 2013-04-16 | Proteus Digital Health, Inc. | Body-associated fluid transport structure evaluation devices |
EP2119465A1 (en) * | 2008-05-16 | 2009-11-18 | Markos Mefar S.P.A. | Nebulizer with breathing phase detecting sensor for delivering nebulized drugs to a user |
US20090308945A1 (en) * | 2008-06-17 | 2009-12-17 | Jacob Loverich | Liquid dispensing apparatus using a passive liquid metering method |
US8348177B2 (en) | 2008-06-17 | 2013-01-08 | Davicon Corporation | Liquid dispensing apparatus using a passive liquid metering method |
WO2010107957A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107955A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING |
WO2010107958A1 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010107952A2 (en) | 2009-03-19 | 2010-09-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111490A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111464A1 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111471A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
WO2010111468A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) |
WO2010111497A2 (en) | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US20120318259A1 (en) * | 2010-01-12 | 2012-12-20 | Omega Life Science Ltd. | Method and apparatus for producing fine concentrated aerosol |
US10857311B2 (en) | 2010-01-12 | 2020-12-08 | Omega Life Science Ltd. | Method and apparatus for producing fine concentrated aerosol |
US10376218B2 (en) | 2010-02-01 | 2019-08-13 | Proteus Digital Health, Inc. | Data gathering system |
US9014779B2 (en) | 2010-02-01 | 2015-04-21 | Proteus Digital Health, Inc. | Data gathering system |
US9008761B2 (en) | 2010-02-01 | 2015-04-14 | Proteus Digital Health, Inc. | Two-wrist data gathering system |
US8332020B2 (en) | 2010-02-01 | 2012-12-11 | Proteus Digital Health, Inc. | Two-wrist data gathering system |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
US11011270B2 (en) | 2010-07-15 | 2021-05-18 | Eyenovia, Inc. | Drop generating device |
US8733935B2 (en) | 2010-07-15 | 2014-05-27 | Corinthian Ophthalmic, Inc. | Method and system for performing remote treatment and monitoring |
US11398306B2 (en) | 2010-07-15 | 2022-07-26 | Eyenovia, Inc. | Ophthalmic drug delivery |
US9087145B2 (en) | 2010-07-15 | 2015-07-21 | Eyenovia, Inc. | Ophthalmic drug delivery |
US10839960B2 (en) | 2010-07-15 | 2020-11-17 | Eyenovia, Inc. | Ophthalmic drug delivery |
US11839487B2 (en) | 2010-07-15 | 2023-12-12 | Eyenovia, Inc. | Ophthalmic drug delivery |
US8684980B2 (en) | 2010-07-15 | 2014-04-01 | Corinthian Ophthalmic, Inc. | Drop generating device |
US10073949B2 (en) | 2010-07-15 | 2018-09-11 | Eyenovia, Inc. | Ophthalmic drug delivery |
WO2012156724A2 (en) | 2011-05-16 | 2012-11-22 | The Technology Partnership Plc | Separable membrane improvements |
US10195633B2 (en) * | 2011-05-16 | 2019-02-05 | The Technology Partnership Plc | Separable membrane improvements |
US20140110500A1 (en) * | 2011-05-16 | 2014-04-24 | The Technology Partnership Plc. | Separable membrane improvements |
US20130108748A1 (en) * | 2011-11-01 | 2013-05-02 | Pepsico., Inc. | Dispensing Nozzle with an Ultrasound Activator |
US9565870B2 (en) * | 2011-11-01 | 2017-02-14 | Pepsico, Inc. | Dispensing nozzle with an ultrasound activator |
US10646373B2 (en) | 2011-12-12 | 2020-05-12 | Eyenovia, Inc. | Ejector mechanism, ejector device, and methods of use |
US10639194B2 (en) | 2011-12-12 | 2020-05-05 | Eyenovia, Inc. | High modulus polymeric ejector mechanism, ejector device, and methods of use |
US20140053835A1 (en) * | 2012-02-16 | 2014-02-27 | Capnia, Inc. | Gas dispenser with diffusing nosepiece |
US9961941B2 (en) | 2012-02-22 | 2018-05-08 | Altria Client Services Llc | Electronic smoking article |
US10299516B2 (en) | 2012-02-22 | 2019-05-28 | Altria Client Services Llc | Electronic article |
US9532597B2 (en) | 2012-02-22 | 2017-01-03 | Altria Client Services Llc | Electronic smoking article |
US10195634B2 (en) | 2013-07-09 | 2019-02-05 | The Technology Partnership Plc | Separable membrane improvements |
US11090676B2 (en) | 2013-07-09 | 2021-08-17 | The Technology Partnership Plc | Separable membrane improvements |
US20170021114A1 (en) * | 2014-04-03 | 2017-01-26 | Csl Behring Ag | Nebulization of immunoglobulin |
US11471617B2 (en) * | 2014-04-03 | 2022-10-18 | Csl Behring Ag | Nebultzation of immunoglobulin |
US10369301B2 (en) | 2014-10-13 | 2019-08-06 | Omega Life Science Ltd. | Nebulizers and uses thereof |
US10052443B2 (en) | 2014-10-13 | 2018-08-21 | Omega Life Science Ltd. | Nebulizers and uses thereof |
US10799652B2 (en) | 2015-01-08 | 2020-10-13 | Convexity Scientific Inc. | Nebulizer device |
US11819453B2 (en) | 2015-01-12 | 2023-11-21 | Novartis Ag | Micro-droplet delivery device and methods |
US10624781B2 (en) | 2015-01-12 | 2020-04-21 | Kedalion Therapeutics, Inc. | Micro-droplet delivery device and methods |
US10583038B2 (en) | 2015-04-10 | 2020-03-10 | Kedalion Therapeutics | Piezoelectric dispenser with replaceable ampoule |
WO2017006091A1 (en) | 2015-07-03 | 2017-01-12 | The Technology Partnership Plc | Aerosol apparatus with improved separable membrane |
WO2017051181A1 (en) | 2015-09-22 | 2017-03-30 | The Technology Partnership Plc | Liquid nicotine formulation |
WO2017064473A1 (en) | 2015-10-16 | 2017-04-20 | The Technology Partnership Plc | Linear droplet generating device |
AU2016344191B2 (en) * | 2015-10-30 | 2021-07-15 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
IL258634B (en) * | 2015-10-30 | 2022-09-01 | Johnson & Johnson Consumer Inc | Aseptic aerosol misting device |
WO2017075318A1 (en) * | 2015-10-30 | 2017-05-04 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
RU2728719C2 (en) * | 2015-10-30 | 2020-07-30 | Джонсон энд Джонсон Консьюмер Инк. | Aseptic aerosol fogger |
US11583885B2 (en) | 2015-10-30 | 2023-02-21 | Johnson & Johnson Consumer Inc. | Unit dose aseptic aerosol misting device |
US11571704B2 (en) | 2015-10-30 | 2023-02-07 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
CN108348697A (en) * | 2015-10-30 | 2018-07-31 | 强生消费者公司 | Sterile aerosol atomising device |
JP2018538030A (en) * | 2015-10-30 | 2018-12-27 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Aseptic aerosol mist spraying device |
US11253885B2 (en) | 2015-10-30 | 2022-02-22 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
CN108348697B (en) * | 2015-10-30 | 2021-09-10 | 强生消费者公司 | Sterile aerosol atomization device |
US10239085B2 (en) | 2015-10-30 | 2019-03-26 | Johnson & Johnson Consumer Inc. | Aseptic aerosol misting device |
WO2017090011A1 (en) * | 2015-11-26 | 2017-06-01 | Ferrari Brands S.R.L. | Device to deliver a substance |
US10433580B2 (en) | 2016-03-03 | 2019-10-08 | Altria Client Services Llc | Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge |
US10455863B2 (en) | 2016-03-03 | 2019-10-29 | Altria Client Services Llc | Cartridge for electronic vaping device |
US10368580B2 (en) | 2016-03-08 | 2019-08-06 | Altria Client Services Llc | Combined cartridge for electronic vaping device |
US10357060B2 (en) | 2016-03-11 | 2019-07-23 | Altria Client Services Llc | E-vaping device cartridge holder |
US10368581B2 (en) | 2016-03-11 | 2019-08-06 | Altria Client Services Llc | Multiple dispersion generator e-vaping device |
US10888454B2 (en) | 2017-01-20 | 2021-01-12 | Kedalion Therapeutics, Inc. | Piezoelectric fluid dispenser |
US11278448B2 (en) | 2017-12-08 | 2022-03-22 | Kedalion Therapeutics, Inc. | Fluid delivery alignment system |
US20200129709A1 (en) * | 2018-10-28 | 2020-04-30 | Albert Ky | Wearable inspiration synchronic ultrasonic nebulizer-humidifier device |
US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
CN110721865A (en) * | 2019-11-07 | 2020-01-24 | 湖南嘉业达电子有限公司 | Atomizing device for atomizing essential oil |
US11298472B2 (en) * | 2020-04-24 | 2022-04-12 | SOSD Health & Medical Innovations Inc. | Ultrasonic nebulizer |
US11925577B2 (en) | 2021-04-16 | 2024-03-12 | Bausch + Lomb Ireland Limted | Hydrodynamically actuated preservative free dispensing system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3812854A (en) | Ultrasonic nebulizer | |
US5515841A (en) | Inhaler | |
EP1332006B1 (en) | Device and method for detecting and controlling liquid supply to an apparatus discharging liquid | |
US20210068455A1 (en) | Substitute smoking device comprising multiple aerosols and passive aerosol generation | |
US6601581B1 (en) | Method and device for ultrasound drug delivery | |
US5586550A (en) | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system | |
EP0794838B1 (en) | Liquid dispensing apparatus and methods | |
US7174888B2 (en) | Liquid dispensing apparatus and methods | |
US6539937B1 (en) | Method of maximizing the mechanical displacement of a piezoelectric nebulizer apparatus | |
US6530370B1 (en) | Nebulizer apparatus | |
JP4589862B2 (en) | Nebulizer for inhalation | |
CA2130827A1 (en) | Powder Nebulizer Apparatus and Method of Nebulization | |
EP0923957A1 (en) | Liquid droplet spray device for an inhaler suitable for respiratory therapies | |
MY104600A (en) | Electroacoustic droplet production apparatus and method | |
GB2345869A (en) | Formation of monodisperse particles | |
WO2023125499A1 (en) | Metered-dose atomization module, atomizer, spray assembly and use thereof | |
WO2023108316A1 (en) | Portable precise visual atomization delivery device based on surface acoustic wave technology | |
CN114470433A (en) | Portable accurate visual atomizing delivery equipment based on surface acoustic wave technology | |
WO2022219623A1 (en) | Nebulizer |